Report overview
Cardiovascular diagnostics are the tests performed on patients for screening and monitoring of heart to diagnose any prevalent cardiac disorders.
This report contains market size and forecasts of Cardiovascular Diagnostic Testing in global, including the following market information:
Global Cardiovascular Diagnostic Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cardiovascular Diagnostic Testing Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cardiovascular Diagnostic Testing companies in 2021 (%)
The global Cardiovascular Diagnostic Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Lipoprotein Test Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cardiovascular Diagnostic Testing include Abbott Laboratories, BD, bioM?rieux, Bio-Rad Laboratories, Danaher Corporation, F. Hoffmann-La Roche, PerkinElmer, Siemens AG and Thermo Fisher Scientific and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Cardiovascular Diagnostic Testing manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cardiovascular Diagnostic Testing Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Diagnostic Testing Market Segment Percentages, by Type, 2021 (%)
Lipoprotein Test
Angiotensin Test
Fibrinogen Test
Serum Uric Acid Test
Global Cardiovascular Diagnostic Testing Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Diagnostic Testing Market Segment Percentages, by Application, 2021 (%)
Laboratory Testing Facilities
Point-of-care Testing Facilities
Global Cardiovascular Diagnostic Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cardiovascular Diagnostic Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cardiovascular Diagnostic Testing revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cardiovascular Diagnostic Testing revenues share in global market, 2021 (%)
Key companies Cardiovascular Diagnostic Testing sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cardiovascular Diagnostic Testing sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Abbott Laboratories
BD
bioM?rieux
Bio-Rad Laboratories
Danaher Corporation
F. Hoffmann-La Roche
PerkinElmer
Siemens AG
Thermo Fisher Scientific
Tosoh Corporation
